Home > National Drug Code (NDC) > Moexipril Hydrochloride and Hydrochlorothiazide

Moexipril Hydrochloride and Hydrochlorothiazide - 0093-5214-01 - (Moexipril Hydrochloride and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Moexipril Hydrochloride and Hydrochlorothiazide

Product NDC: 0093-5214
Proprietary Name: Moexipril Hydrochloride and Hydrochlorothiazide
Non Proprietary Name: Moexipril Hydrochloride and Hydrochlorothiazide
Active Ingredient(s): 12.5; 15    mg/1; mg/1 & nbsp;   Moexipril Hydrochloride and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Moexipril Hydrochloride and Hydrochlorothiazide

Product NDC: 0093-5214
Labeler Name: Teva Pharmaceuticals USA Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076980
Marketing Category: ANDA
Start Marketing Date: 20070307

Package Information of Moexipril Hydrochloride and Hydrochlorothiazide

Package NDC: 0093-5214-01
Package Description: 100 TABLET, FILM COATED in 1 BOTTLE (0093-5214-01)

NDC Information of Moexipril Hydrochloride and Hydrochlorothiazide

NDC Code 0093-5214-01
Proprietary Name Moexipril Hydrochloride and Hydrochlorothiazide
Package Description 100 TABLET, FILM COATED in 1 BOTTLE (0093-5214-01)
Product NDC 0093-5214
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Moexipril Hydrochloride and Hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20070307
Marketing Category Name ANDA
Labeler Name Teva Pharmaceuticals USA Inc
Substance Name HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Strength Number 12.5; 15
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Moexipril Hydrochloride and Hydrochlorothiazide


General Information